Skip to content

Three-part PK and PD study of AXN-027

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524019-35-00
Enrollment
64
Registered
2026-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and other neurological disorders of excitation/inhibition (E/I) imbalance within neuronal circuits., Chronic pain, refractory epilepsy

Interventions

None listed

Sponsors

Axonis Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 27, 2026